There are 6 resources available
Introduction
Presenter: Marina Garassino
Session: ESMO Colloquium supported by Eli Lilly and Co. - One tumour, many faces: Optimising testing, targeting and monitoring oncogene-addicted NSCLC beyond EGFR
Resources:
Slides
Webcast
Tissue testing for actionable biomarkers in patients with advanced NSCLC: Scientific and implementation perspectives and the positioning of molecular tumour boards
Presenter: Fernando Lopez-Rios
Session: ESMO Colloquium supported by Eli Lilly and Co. - One tumour, many faces: Optimising testing, targeting and monitoring oncogene-addicted NSCLC beyond EGFR
Resources:
Slides
Webcast
An overview of molecular epidemiology of rare molecular aberrations and matching treatment strategies for patients with non-EGFR, oncogene-addicted advanced NSCLC
Presenter: Fabrice Barlesi
Session: ESMO Colloquium supported by Eli Lilly and Co. - One tumour, many faces: Optimising testing, targeting and monitoring oncogene-addicted NSCLC beyond EGFR
Resources:
Slides
Webcast
Live Q&A / discussion
Session: ESMO Colloquium supported by Eli Lilly and Co. - One tumour, many faces: Optimising testing, targeting and monitoring oncogene-addicted NSCLC beyond EGFR
Resources:
Webcast
Concluding remarks
Presenter: Fernando Lopez-Rios
Session: ESMO Colloquium supported by Eli Lilly and Co. - One tumour, many faces: Optimising testing, targeting and monitoring oncogene-addicted NSCLC beyond EGFR
Resources:
Webcast
RET-fused NSCLC: State of the art treatment of advanced disease, including sanctuary sites
Presenter: Marina Garassino
Session: ESMO Colloquium supported by Eli Lilly and Co. - One tumour, many faces: Optimising testing, targeting and monitoring oncogene-addicted NSCLC beyond EGFR
Resources:
Slides
Webcast